Literature DB >> 15941964

Menstrual cycle characteristics and incidence of premenopausal breast cancer.

Kathryn L Terry1, Walter C Willett, Janet W Rich-Edwards, David J Hunter, Karin B Michels.   

Abstract

BACKGROUND: Epidemiologic studies have indicated that menstrual cycle characteristics such as age at menarche and age at menopause are associated with breast cancer risk. Anovulation, which is more common with long or irregular cycles, has been hypothesized to reduce the incidence of breast cancer.
METHODS: We analyzed data from the Nurses' Health Study II, a cohort of 116,671 female registered nurses ages 25 to 42 years at baseline. Information on menstrual cycle characteristics was assessed in 1989 and 1993, and incident cases of premenopausal breast cancer were ascertained through 2001.
RESULTS: During 1,135,496 person-years of follow-up (1989-2001), 1,163 incident cases of invasive premenopausal breast cancer were diagnosed. Overall, women with long menstrual cycles at ages 18 to 22 years (>32 days or too irregular to estimate) did not experience a significantly lower breast cancer risk compared with women with normal cycle lengths (26-31 days) at that age [covariate-adjusted hazard ratio (HR), 0.92; 95% confidence interval (95% CI), 0.79-1.06]. Among women ages <40 years, those with menstrual cycles lasting >32 days or too irregular to estimate at ages 18 to 22 years had a decreased incidence of breast cancer (covariate-adjusted HR, 0.71; 95% CI, 0.53-0.97). Current menstrual cycle characteristics were not associated with breast cancer incidence.
CONCLUSION: Overall, longer or irregular cycles at ages 18 to 22 years or in early adulthood were not associated with reduced premenopausal breast cancer risk. However, longer menstrual cycles at ages 18 to 22 years were associated with a lower incidence of premenopausal breast cancer before age 40.

Entities:  

Mesh:

Year:  2005        PMID: 15941964      PMCID: PMC2293279          DOI: 10.1158/1055-9965.EPI-05-0051

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  24 in total

1.  Cumulative number of menstrual cycles and breast cancer risk: results from the E3N cohort study of French women.

Authors:  F Clavel-Chapelon
Journal:  Cancer Causes Control       Date:  2002-11       Impact factor: 2.506

2.  Menstrual cycle characteristics and history of ovulatory infertility in relation to breast cancer risk in a large cohort of US women.

Authors:  M Garland; D J Hunter; G A Colditz; J E Manson; M J Stampfer; D Spiegelman; F Speizer; W C Willett
Journal:  Am J Epidemiol       Date:  1998-04-01       Impact factor: 4.897

3.  Do regular ovulatory cycles increase breast cancer risk?

Authors:  B E Henderson; R K Ross; H L Judd; M D Krailo; M C Pike
Journal:  Cancer       Date:  1985-09-01       Impact factor: 6.860

4.  The Nurses' Health Study: 20-year contribution to the understanding of health among women.

Authors:  G A Colditz; J E Manson; S E Hankinson
Journal:  J Womens Health       Date:  1997-02       Impact factor: 2.681

5.  Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa.

Authors:  K E Anderson; T A Sellers; P L Chen; S S Rich; C P Hong; A R Folsom
Journal:  Cancer       Date:  1997-02-01       Impact factor: 6.860

6.  Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study.

Authors:  Y T Gao; X O Shu; Q Dai; J D Potter; L A Brinton; W Wen; T A Sellers; L H Kushi; Z Ruan; R M Bostick; F Jin; W Zheng
Journal:  Int J Cancer       Date:  2000-07-15       Impact factor: 7.396

7.  Association of correlates of endogenous hormonal exposure with breast cancer risk in 426 families (United States).

Authors:  Dawn M Grabrick; Robert A Vierkant; Kristin E Anderson; James R Cerhan; V Elving Anderson; Thomas A Seller
Journal:  Cancer Causes Control       Date:  2002-05       Impact factor: 2.506

8.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

9.  Regularity and length of menstrual cycles in women aged 41-46 in relation to breast cancer risk: results from the DOM-project.

Authors:  I den Tonkelaar; F de Waard
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

10.  Mortality of women with polycystic ovary syndrome at long-term follow-up.

Authors:  T Pierpoint; P M McKeigue; A J Isaacs; S H Wild; H S Jacobs
Journal:  J Clin Epidemiol       Date:  1998-07       Impact factor: 6.437

View more
  16 in total

1.  Dietary Fiber Intake in Young Adults and Breast Cancer Risk.

Authors:  Maryam S Farvid; A Heather Eliassen; Eunyoung Cho; Xiaomei Liao; Wendy Y Chen; Walter C Willett
Journal:  Pediatrics       Date:  2016-02-01       Impact factor: 7.124

2.  Associations between psychiatric disorders and menstrual cycle characteristics.

Authors:  Mary Lee Barron; Louise H Flick; Cynthia A Cook; Sharon M Homan; Claudia Campbell
Journal:  Arch Psychiatr Nurs       Date:  2008-10       Impact factor: 2.218

3.  Progesterone and ovulation across stages of the transition to menopause.

Authors:  Kathleen A O'Connor; Rebecca Ferrell; Eleanor Brindle; Benjamin Trumble; Jane Shofer; Darryl J Holman; Maxine Weinstein
Journal:  Menopause       Date:  2009 Nov-Dec       Impact factor: 2.953

4.  Reproductive endocrinology: menstrual cycle lengths--what can they tell us?

Authors:  Shahla Nader
Journal:  Nat Rev Endocrinol       Date:  2012-09-25       Impact factor: 43.330

5.  Purposeful exercise and lifestyle physical activity in the lives of young adult women: findings from a diary study.

Authors:  Maureen O'Dougherty; Andrea Arikawa; Beth C Kaufman; Mindy S Kurzer; Kathryn H Schmitz
Journal:  Women Health       Date:  2009-12

6.  Association between reproductive factors and urinary estrogens and estrogen metabolites in premenopausal women.

Authors:  Renée T Fortner; Susan E Hankinson; Catherine Schairer; Xia Xu; Regina G Ziegler; A Heather Eliassen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-03-27       Impact factor: 4.254

7.  Maternal early life factors associated with hormone levels and the risk of having a child with an autism spectrum disorder in the nurses health study II.

Authors:  Kristen Lyall; David L Pauls; Susan L Santangelo; Susan Santangelo; Donna Spiegelman; Alberto Ascherio
Journal:  J Autism Dev Disord       Date:  2011-05

8.  Accuracy of reporting of menstrual cycle length.

Authors:  Anne Marie Zaura Jukic; Clarice R Weinberg; Allen J Wilcox; D Robert McConnaughey; Paige Hornsby; Donna D Baird
Journal:  Am J Epidemiol       Date:  2007-10-10       Impact factor: 4.897

9.  The utility of menstrual cycle length as an indicator of cumulative hormonal exposure.

Authors:  Sunni L Mumford; Anne Z Steiner; Anna Z Pollack; Neil J Perkins; Amanda C Filiberto; Paul S Albert; Donald R Mattison; Jean Wactawski-Wende; Enrique F Schisterman
Journal:  J Clin Endocrinol Metab       Date:  2012-07-26       Impact factor: 5.958

Review 10.  Exposures to synthetic estrogens at different times during the life, and their effect on breast cancer risk.

Authors:  Leena Hilakivi-Clarke; Sonia de Assis; Anni Warri
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-02-08       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.